Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Natural Order Acquisition Corp. (NOAC)

9.83   0 (0%) 05-16 07:31
Open: 9.83 Pre. Close: 9.83
High: 9.8325 Low: 9.83
Volume: 1,900 Market Cap: 283(M)
Natural Order Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to focus on companies that use plant-based, cell-based, or precision fermentation technologies for developing food products that eliminate animals from the food supply chain. The company was incorporated in 2020 and is based in Weston, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.86 - 9.9 9.9 - 9.94
Low: 9.69 - 9.76 9.76 - 9.81
Close: 9.74 - 9.84 9.84 - 9.92

Technical analysis

as of: 2022-05-13 4:40:09 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 11.56     One year: 11.62
Support: Support1: 9.81    Support2: 8.17
Resistance: Resistance1: 9.9    Resistance2: 9.94
Pivot: 9.86
Moving Average: MA(5): 9.84     MA(20): 9.86
MA(100): 9.82     MA(250): 9.79
MACD: MACD(12,26): -0.1     Signal(9): 0
Stochastic oscillator: %K(14,3): 6.4     %D(3): 6.7
RSI: RSI(14): 43.1
52-week: High: 9.98  Low: 9.6
Average Vol(K): 3-Month: 44 (K)  10-Days: 15 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ NOAC ] has closed above bottom band by 17.0%. Bollinger Bands are 51.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Headline News

Sat, 14 May 2022
Novel Oral AntiCoagulants (NOAC) Market by Type (Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors), Application (Deep Vein Thrombosis (DVT), Pulmonary Embolism, Acute Coronary Syndrome, Hemodialysis, Others), and Geography – Global Trends & - ManufactureLink

Wed, 11 May 2022
Safety and effectiveness of oral anticoagulation in patients with atrial fibrillation and renal insufficiency - a real-world perspective - DocWire News

Wed, 04 May 2022
Tierney Brothers Share Eagle Court of Honor - Over the Mountain Journal

Sun, 01 May 2022
Natural Order Acquisition Corp. (NASDAQ:NOAC) Short Interest Up 52.0% in April - Defense World

Fri, 29 Apr 2022
The Effect of Switching From Warfarin to Novel Oral Anticoagulants on Patients' Satisfaction and the Travel Burden in a Rural Setting - Cureus

Tue, 19 Apr 2022
Eliquis adds cancer-associated VTE treatment in approval conditions - KBR

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Financial Services
Industry:  Shell Companies
Shares Out. 29 (M)
Shares Float 22 (M)
% Held by Insiders 22.4 (%)
% Held by Institutions 51.3 (%)
Shares Short 69 (K)
Shares Short P.Month 16 (K)

Stock Financials

EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.38
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow -1 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value -26.57
Price to Sales 0
Price to Cash Flow -391.7

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.